Non-cutting CRISPR activation

Switching on the skin's own genes to rebuild collagen.

We reactivate the skin's own collagen genes —
without cutting DNA.

We don't deliver collagen. We switch the skin's own collagen program back on.
What we're building
01 — Scientific validation

Validated across key
dermal ECM genes

Demonstrated activation across key dermal ECM genes, including simultaneous activation of multiple targets in human cells, with increased collagen expression observed in an early in vivo study.

02 — Platform & pipeline

A focused first indication,
a programmable platform

Starting with steroid-induced skin atrophy — with broader applications across skin regeneration and skin aging.

Team
Co-founder & CEO
Jooyoung Ahn

An engineer with experience in offshore plant design, airframe development, and accelerator R&D.

Co-founder & CTO
Injoo Hwang, Ph.D.

A medical scientist who developed the platform, specializing in CRISPR and regenerative medicine.

Get in touch

Let's rebuild what
the skin loses.

For partnerships, investment, or scientific collaboration, we'd like to hear from you.

Email Criscope